ConcertAI’s TeraRecon has launched an upgraded Eureka Clinical AI platform. Designed to facilitate collaboration for the entire care team, the platform serves as an end-to-end clinical application integrating multiple AI algorithms and workflows. This release expands Eureka Clinical AI to streamline clinical solutions and care coordination with support for longitudinal AI analysis, desktop chat, and tailored multi-AI algorithm workflows.
“The Eureka Clinical AI platform is unique in supporting third-party, customer-developed, and TeraRecon-developed AI algorithms on one unified, open, AI clinical platform,” says Jeff Elton, PhD, CEO of ConcertAI. “When using Eureka Clinical AI, customers get the benefit of multi-AI model workflows tailored to their individual institution preferences and requirements and clear notifications on AI interpretation execution and performance.”
Dan McSweeney, president of TeraRecon, adds: “A high-performance AI ecosystem is fundamentally built on four key pillars: First is the comprehensive ability to host all forms of AI, including customer-developed, TeraRecon-developed, and third-party algorithms. Second is physician-centricity in that the platform enables the clinician and reaffirms their role in the decision-making process and diagnosis. Third is integration, in that the AI platform can serve as the single point of access for consolidating AI solutions, minimizing the burden to procure new AI algorithms, standardizing the deployment process, and seamlessly integrating into providers’ enterprise imaging systems.”
Eureka Clinical AI is open to third-party AI algorithms, allowing consolidated management of all AI interpretation solutions with PACS or EMR integrations. Multi-specialty care teams can see results and receive mobile alerts to confirm AI findings, ensuring timely patient interventions, management, and coordinated care delivery, company officials say.
